1,539 results on '"Kodama, Tatsuhiko"'
Search Results
2. Intralesional pentraxin 3 increases with atherosclerotic disease progression, but may protect from thrombosis: Friend or foe?
3. Antibody-mimetic drug conjugate with efficient internalization activity using anti-HER2 VHH and duocarmycin
4. Lessons from PROMINENT and prospects for pemafibrate
5. In vivo-stable bis-iminobiotin for targeted radionuclide delivery with the mutant streptavidin
6. Humoral immunity after second dose of BNT162b2 vaccine in Japanese communities: an observational cross-sectional study, Fukushima Vaccination Community Survey
7. MYPT1-PP1β phosphatase negatively regulates both chromatin landscape and co-activator recruitment for beige adipogenesis
8. Author Correction: Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1
9. Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1
10. Gastrin-releasing peptide regulates fear learning under stressed conditions via activation of the amygdalostriatal transition area
11. Single-cell transcriptomes underscore genetically distinct tumor characteristics and microenvironment for hereditary kidney cancers
12. Suv4-20h2 protects against influenza virus infection by suppression of chromatin loop formation
13. Orchestration of myeloid-derived suppressor cells in the tumor microenvironment by ubiquitous cellular protein TCTP released by tumor cells
14. Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan
15. Spatiotemporal dynamics of SETD5-containing NCoR–HDAC3 complex determines enhancer activation for adipogenesis
16. Antibody Profiling of Microbial Antigens in the Blood of COVID-19 mRNA Vaccine Recipients Using Microbial Protein Microarrays
17. Hypoxia activates SREBP2 through Golgi disassembly in bone marrow‐derived monocytes for enhanced tumor growth
18. Acidic extracellular pH drives accumulation of N1-acetylspermidine and recruitment of protumor neutrophils
19. Chd4 choreographs self-antigen expression for central immune tolerance
20. Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?
21. Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis
22. Five doses of the mRNA vaccination potentially suppress ancestral-strain stimulated SARS-CoV2-specific cellular immunity: a cohort study from the Fukushima vaccination community survey, Japan
23. Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinoma
24. Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα) in the Metabolic Syndrome: Is Pemafibrate Light at the End of the Tunnel?
25. Mouse Lacking COUP-TFII as an Animal Model of Bochdalek-Type Congenital Diaphragmatic Hernia
26. Supplementary Methods, Figure Legends, Figures 1 - 20 from Inhibition of Histone Demethylase JMJD1A Improves Anti-Angiogenic Therapy and Reduces Tumor-Associated Macrophages
27. Data from Inhibition of Histone Demethylase JMJD1A Improves Anti-Angiogenic Therapy and Reduces Tumor-Associated Macrophages
28. Supplementary Table 3 from Inhibition of Histone Demethylase JMJD1A Improves Anti-Angiogenic Therapy and Reduces Tumor-Associated Macrophages
29. Supplementary Table 1 from Inhibition of Histone Demethylase JMJD1A Improves Anti-Angiogenic Therapy and Reduces Tumor-Associated Macrophages
30. Supplementary Table 4 from Inhibition of Histone Demethylase JMJD1A Improves Anti-Angiogenic Therapy and Reduces Tumor-Associated Macrophages
31. Supplementary Table 2 from Inhibition of Histone Demethylase JMJD1A Improves Anti-Angiogenic Therapy and Reduces Tumor-Associated Macrophages
32. Activation of Peroxisome Proliferator-Activated Receptor δ Induces Fatty Acid β-Oxidation in Skeletal Muscle and Attenuates Metabolic Syndrome
33. PPARα activation directly upregulates thrombomodulin in the diabetic retina
34. Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content
35. Antiatherogenic Effects of the Antioxidant BO-653 in Three Different Animal Models
36. Mitochondrial Biogenesis in White Adipose Tissue Mediated by JMJD1A-PGC-1 Axis Limits Age-Related Metabolic Disease
37. Role for the Class A Macrophage Scavenger Receptor in the Phagocytosis of Apoptotic Thymocytes in vitro
38. Involvement of Specific Macrophage-Lineage Cells Surrounding Arterioles in Barrier and Scavenger Function in Brain Cortex
39. Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial
40. PGE2 induced in and released by dying cells functions as an inhibitory DAMP
41. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
42. Association of systemic adverse reaction patterns with long-term dynamics of humoral and cellular immunity after coronavirus disease 2019 third vaccination.
43. Crystal structure of streptavidin mutant with low immunogenicity
44. Differential expression of pentraxin 3 in neutrophils
45. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
46. Pathological complete remission of relapsed tumor by photo‐activating antibody–mimetic drug conjugate treatment
47. MAFB prevents excess inflammation after ischemic stroke by accelerating clearance of damage signals through MSR1
48. Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn
49. Stratifying elicited antibody dynamics after two doses of SARS-CoV-2 vaccine in a community-based cohort in Fukushima, Japan
50. Factors associated with anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein antibody titer and neutralizing activity among healthcare workers following vaccination with the BNT162b2 vaccine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.